K. O̸lgaard

Reduced vitamin D-induced cathelicidin production and killing of Mycobacterium tuberculosis in macrophages from a patient with a non-functional vitamin D receptor: A case report
20228 citationsauthor #10
Hypomorphic expression of parathyroid Bmal1 disrupts the internal parathyroid circadian clock and increases parathyroid cell proliferation in response to uremia.
202212 citationsauthor #10
MO553: Impact of the Internal Parathyroid Clock on the Regulation of Parathyroid Gene Expression
20220 citationsauthor #5
The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization
202211 citationsauthor #6
Extrarenal expression of α-klotho, the kidney related longevity gene, in Heterocephalus glaber, the long living Naked Mole Rat
20213 citationsauthor #10
The Vascular Circadian Clock in Chronic Kidney Disease
20217 citationsauthor #3
New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease–Mineral and Bone Disorder
202117 citationsauthor #4
Effect of NAD+ boosting on kidney ischemia-reperfusion injury
202131 citationsauthor #7
Impaired Vitamin D Signaling in T Cells From a Family With Hereditary Vitamin D Resistant Rickets
202112 citationsauthor #9
Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease
20219 citationsauthor #7
Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
202035 citationsauthor #10
MO054VASCULAR CALCIFICATION IMPAIRS BONE MINERALIZATION
20200 citationsauthor #8
A molecular circadian clock operates in the parathyroid gland and is disturbed in chronic kidney disease associated bone and mineral disorder.
202029 citationsauthor #9
Circadian rhythms of mineral metabolism in chronic kidney disease-mineral bone disorder.
202023 citationsauthor #2
New Aspects of the Kidney in the Regulation of Fibroblast Growth Factor 23 (FGF23) and Mineral Homeostasis
202056 citationsauthor #2
Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats
201927 citationsauthor #6
Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications
201816 citationsauthor #8
FP375EFFECT OF WNT-INHIBITION ON ESTABLISHED VASCULAR CALCIFICATION IN UREMIC RATS
20180 citationsauthor #5
Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification
201820 citationsauthor #8
SaO026AORTA EXPRESSION OF CORE CIRCADIAN CLOCK GENES IS DISRUPTED IN UREMIC VASCULAR CALCIFICATION
20180 citationsauthor #6
FP404ABNORMAL CIRCADIAN RHYTHM IN MINERAL HOMEOSTASIS IN UREMIC RATS
20180 citationsauthor #5
Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.
201836 citationsauthor #6
to elevation of its circulating levels in uremia Kidney fi broblast growth factor 23 does not contribute
20170 citationsauthor #6
Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
201746 citationsauthor #6
Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia
201729 citationsauthor #4
perfused rat liver and kidney Aldosterone metabolism in combined isolated
20160 citationsauthor #3
Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.
201655 citationsauthor #8
Inhibition of the FGF receptor decreases FGF 23 levels in uremia
20160 citationsauthor #3
The vascular secret of Klotho.
201525 citationsauthor #2
A potential kidney - bone axis involved in the rapid minute-to-minute regulation of plasma Ca2+
201517 citationsauthor #4
Key role of the kidney in the regulation of fibroblast growth factor 23.
201565 citationsauthor #4
A Randomized Study Evaluating Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients With Persistent Hyperparathyroidism
2014102 citationsauthor #6
Parathyroid hormone-related peptide plasma concentrations in patients on hemodialysis
20146 citationsauthor #3
Circulating FGF23 Levels in Response to Acute Changes in Plasma Ca2+
20140 citationsauthor #4
In memoriam: Claus Brun, MD, Dr Med, 1914-2014.
20141 citationsauthor #3
A kidney-bone axis involved in the rapid minute-to-minute regulation of plasma Ca
20140 citationsauthor #4
Circulating FGF23 Levels in Response to Acute Changes in Plasma Ca2+
201418 citationsauthor #4
Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4–5
201331 citationsauthor #4
High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
201329 citationsauthor #5
Report on 2012 ISN Nexus symposium: 'Bone and the kidney'.
20136 citationsauthor #2
Acute macular neuroretinopathy in relation to anti‐thymocyte globulin infusion
201211 citationsauthor #3
Epigenetic Methylation of Parathyroid CaR and VDR Promoters in Experimental Secondary Hyperparathyroidism
201212 citationsauthor #3
Chronic kidney disease: Diagnosis, classification and management
20120 citationsauthor #1
Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD.
201120 citationsauthor #1
The secretory response of parathyroid hormone to acute hypocalcemia in vivo is independent of parathyroid glandular sodium/potassium-ATPase activity.
201116 citationsauthor #4
Increased parathyroid expression of klotho in uremic rats.
201070 citationsauthor #4
Bone disease in renal transplant recipients
20105 citationsauthor #2
Abnormal parathyroid gland function in CKD
20106 citationsauthor #3
Medical therapy in Chronic kidney disease
20102 citationsauthor #4
The Spectrum of Mineral and Bone Disorders in Chronic Kidney Disease
201019 citationsauthor #1
Biochemical markers of bone metabolism in CKD
20101 citationsauthor #2
Vitamin D controls T cell antigen receptor signaling and activation of human T cells
2010566 citationsauthor #4
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.
2010110 citationsauthor #5
The effect of 1-alpha-hydroxycholecalciferol on the renal handling of phosphate in parathyroidectomized man.
20096 citationsauthor #2
Opinion: When is Vitamin D Contraindicated in Dialysis Patients?
20091 citationsauthor #2
Bone Mineral Content in Chronic Renal Failure during Long-Term Treatment with 1α-Hydroxycholecalciferol
20091 citationsauthor #2
Renal handling of phosphate in relation to serum parathyroid hormone levels.
200910 citationsauthor #2
1-Alpha-hydroxycholecalciferol-induced changes in the renal heandling of phosphate and the serum parathyroid hormone level.
20098 citationsauthor #2
Perirenal fibrosis as a cause of uremia and hypertension in human transplanted kidneys.
20090 citationsauthor #3
Plasma aldosterone in anephric and non-nephrectomized dialysis patients in relation to changes in plasma potassium without change in total potassium balance.
200916 citationsauthor #1
Successful immunosuppressive treatment of oliguric extracapillary glomerulonephritis.
20094 citationsauthor #2
The adrenocortical response to angiotensin II infusion in anephric and non-nephrectomized patients on regular hemodialysis.
20095 citationsauthor #1
Ovarian cysts in women on chronic intermittent haemodialysis.
20099 citationsauthor #2
Recurrent attacks of hemolytic anemia, thrombocytopenia and uremia--hemolytic uremic syndrome?
20092 citationsauthor #1
Aldosterone response to ACTH stimulation in anephric and non-nephrectomized patients on regular hemodialysis.
20096 citationsauthor #1
Bone disease - 1
20091 citationsauthor #82
Regulation of plasma aldosterone in anephric and non-nephrectomized patients during hemodialysis treatment.
20096 citationsauthor #1
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.
200856 citationsauthor #6
Reply to Dr S.C. Palmer and co-workers.
20081 citationsauthor #1
Cardiac structure and function in a mouse model of uraemia without hypertension
200816 citationsauthor #4
The impact of HLA-DR compatibility on cadaver kidney graft survival in a prospective study with special emphasis on the quality of typing.
20088 citationsauthor #6
Effect of 1,25-dihydroxy-vitamin D 3 in experimental sepsis
20077 citationsauthor #3
Calcium‐sensing receptor and recovery from hypocalcaemia in thyroparathyroidectomized rats
200713 citationsauthor #3
Effect of 1,25-dihydroxy-vitamin D3 in experimental sepsis
200771 citationsauthor #3
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice
200728 citationsauthor #4
Abnormal Bone and Mineral Metabolism in Kidney Transplant Patients – A Review
200781 citationsauthor #5
Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
20061,927 citationsauthor #6
Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia.
200615 citationsauthor #2
Basic Science and Dialysis: Parathyroid Growth and Suppression in Renal Failure
200617 citationsauthor #3
Parathyroidectomy vs calcimimetics for treatment of persistent hyperparathyroidism after kidney transplantation.
200624 citationsauthor #2
Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands.
200646 citationsauthor #2
Can hyperparathyroid bone disease be arrested or reversed?
20069 citationsauthor #1
Influence of parathyroid mass on the regulation of PTH secretion.
200621 citationsauthor #2
Translational Nephrology Klotho , an important new factor for the activity of Ca 2 þ channels , connecting calcium homeostasis , ageing and uraemia
20061 citationsauthor #2
Clinical Guide to Bone and Mineral Metabolism in CKD
200619 citationsauthor #1
Uremia-Specific Effects in the Arterial Media During Development of Uremic Atherosclerosis in Apolipoprotein E–Deficient Mice
200529 citationsauthor #5
Impaired kidney growth in low-birth-weight children: distinct effects of maturity and weight for gestational age.
2005119 citationsauthor #6
Renal osteodystrophy with special emphasis on secondary hyperparathyroidism
20051 citationsauthor #3
Comparison between 1α(OH)D3 and 1,25(OH)2D3 on the Suppression of Plasma PTH Levels in Uremic Patients, Evaluated by the ‘Whole’ and ‘Intact’ PTH Assays
200510 citationsauthor #3
Nephrology Dialysis Transplantation How to evaluate hypercalcaemia in the patient with chronic renal failure
20050 citationsauthor #1
Vitamin D3-Mediated Regulation of the Antimicrobial Peptides CAMP and DEFB4 Is Evolutionarily Important for Innate Immunity in Humans and Primates.
20050 citationsauthor #4
[Children undergoing chronic hemodialysis. Results from Rigshospitalet, 1991--2002].
20050 citationsauthor #2
NephrologyDialysis Transplantation High-normal calcium (1.35 mmol/1) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone
20050 citationsauthor #3
Author / Subject Indexes for Abstracts
20040 citationsauthor #38
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy.
2004180 citationsauthor #2
Kidney growth in 717 healthy children aged 0–18 months: a longitudinal cohort study
200461 citationsauthor #10
Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure.
200492 citationsauthor #3
Increased kidney growth in formula-fed versus breast-fed healthy infants
200455 citationsauthor #6
Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.
200480 citationsauthor #4
4P-1190 A mouse model of uremic atherosclerosis
20030 citationsauthor #5

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT